TY - JOUR
T1 - Gut microbiota and the role of probiotics in therapy
AU - Quigley, Eamonn M.
PY - 2011/12
Y1 - 2011/12
N2 - Thanks to rapid progress in the development and application of molecular techniques to the assessment of the human gut microbiome, the true nature, diversity and metabolic potential of this 'hidden organ' are being revealed. Simultaneously, the complex physiological, immunological and metabolic interactions between host and microbiome are being untangled. By contrast, the probiotic concept has been with us for decades and, while supported more by fad and folklore in the past, is now gaining support, not only from experimental work in animal models, but also by well-designed studies in human diseases, most notably infectious diarrheas, inflammatory bowel disease and the irritable bowel syndrome.
AB - Thanks to rapid progress in the development and application of molecular techniques to the assessment of the human gut microbiome, the true nature, diversity and metabolic potential of this 'hidden organ' are being revealed. Simultaneously, the complex physiological, immunological and metabolic interactions between host and microbiome are being untangled. By contrast, the probiotic concept has been with us for decades and, while supported more by fad and folklore in the past, is now gaining support, not only from experimental work in animal models, but also by well-designed studies in human diseases, most notably infectious diarrheas, inflammatory bowel disease and the irritable bowel syndrome.
UR - http://www.scopus.com/inward/record.url?scp=82255162672&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=82255162672&partnerID=8YFLogxK
U2 - 10.1016/j.coph.2011.09.010
DO - 10.1016/j.coph.2011.09.010
M3 - Review article
C2 - 21996283
AN - SCOPUS:82255162672
SN - 1471-4892
VL - 11
SP - 593
EP - 603
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
IS - 6
ER -